Search research articles
Contact Us
Filters
Showing results (131-140 of 355) with videos related to
Page
of 36
Sort By:
Frontiers in Immunology
|
September 28, 2020
Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference
Fabio Marino, Aikaterini Semilietof, Justine Michaux, et al.
Nature Reviews. Clinical Oncology
|
September 4, 2024
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
Eleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
The American Journal of Pathology
|
July 4, 2006
Involvement of endothelial CD44 during in vivo angiogenesis
Gaoyuan Cao, Rashmin C Savani, Melane Fehrenbach, et al.
Cancer Research
|
April 19, 2007
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization
Joel Greshock, Katherine Nathanson, Anne-Marie Martin, et al.
Disease Markers
|
December 7, 2007
Immune prognostic factors in ovarian cancer: lessons from translational research
Phyllis A Gimotty, Lin Zhang, Ioannis Alagkiozidis, et al.
Current Pharmaceutical Design
|
February 26, 2013
Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology
Jalal Abdolalizadeh, Mohammad Nouri, Jafar Majidi Zolbanin, et al.
Revue Medicale Suisse
|
May 16, 2019
[Side effects of immune checkpoint inhibitors: diagnosis and management]
Claire Perrinjaquet, Maged Zaher, Daniela Aleida Ferraro, et al.
Bioimpacts : BI
|
January 28, 2022
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
Efthymia-Iliana Matthaiou, Yi Guo, Jaleh Barar, et al.
Human Gene Therapy
|
March 28, 2002
Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation
Stephanie V Blank, Stephen C Rubin, George Coukos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2013
CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor
Qunrui Ye, De-Gang Song, Mathilde Poussin, et al.
Page
of 36
Search research articles
Search
Showing results (131-140 of 355) with videos related to
Sort By:
Page
of 36
Frontiers in Immunology
|
September 28, 2020
Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference
Fabio Marino, Aikaterini Semilietof, Justine Michaux, et al.
Nature Reviews. Clinical Oncology
|
September 4, 2024
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
Eleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
The American Journal of Pathology
|
July 4, 2006
Involvement of endothelial CD44 during in vivo angiogenesis
Gaoyuan Cao, Rashmin C Savani, Melane Fehrenbach, et al.
Cancer Research
|
April 19, 2007
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization
Joel Greshock, Katherine Nathanson, Anne-Marie Martin, et al.
Disease Markers
|
December 7, 2007
Immune prognostic factors in ovarian cancer: lessons from translational research
Phyllis A Gimotty, Lin Zhang, Ioannis Alagkiozidis, et al.
Current Pharmaceutical Design
|
February 26, 2013
Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology
Jalal Abdolalizadeh, Mohammad Nouri, Jafar Majidi Zolbanin, et al.
Revue Medicale Suisse
|
May 16, 2019
[Side effects of immune checkpoint inhibitors: diagnosis and management]
Claire Perrinjaquet, Maged Zaher, Daniela Aleida Ferraro, et al.
Bioimpacts : BI
|
January 28, 2022
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
Efthymia-Iliana Matthaiou, Yi Guo, Jaleh Barar, et al.
Human Gene Therapy
|
March 28, 2002
Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation
Stephanie V Blank, Stephen C Rubin, George Coukos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2013
CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor
Qunrui Ye, De-Gang Song, Mathilde Poussin, et al.
Page
of 36